Stay updated on Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Sign up to get notified when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, representing a small update to the page’s underlying template or software. This change does not alter study content or visible functionality.
    Difference
    0.1%
    Check dated 2026-05-16T09:30:23.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    This updates the displayed revision/version indicator for the page from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-25T05:13:22.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T23:53:09.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.5.0. The previous v3.4.3 label was removed.
    Difference
    0.1%
    Check dated 2026-03-20T00:48:10.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:29:41.000Z thumbnail image
  9. Check
    106 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:23:58.000Z thumbnail image

Stay in the know with updates to Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.